Xeris Biopharma (XERS) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Xeris Biopharma (XERS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 83M (-3.12%) | 86M (+15.37%) | 74M (+3.97%) | 72M (+19.00%) | 60M (+0.03%) | 60M (+10.74%) | 54M (+12.90%) | 48M (+18.28%) | 41M (-8.45%) | 44M (-8.13%) | 48M (+27.12%) | 38M (+14.49%) | 33M (+0.18%) | 33M (+11.47%) | 30M (+17.46%) | 25M (+14.68%) | 22M (+2.32%) | 22M (+95.03%) | 11M (+24.13%) | 8.91M (+10.68%) | 8.05M (-25.12%) | 11M (+14.36%) | 9.40M | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7.84M | 7.84M | - | - | -6.62M | 6.62M | - | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 8.78M (+11.56%) | 7.87M (+5.21%) | 7.48M (-7.20%) | 8.06M (+4.00%) | 7.75M (+27.26%) | 6.09M (+3.40%) | 5.89M (+2.26%) | 5.76M (-26.34%) | 7.82M (+22.57%) | 6.38M (+26.84%) | 5.03M (-17.41%) | 6.09M (+25.83%) | 4.84M (-2.42%) | 4.96M (-17.88%) | 6.04M (+62.37%) | 3.72M (-40.48%) | 6.25M (-38.00%) | 10M (+78.09%) | 5.66M (+5.20%) | 5.38M (+33.50%) | 4.03M (-76.36%) | 17M (+339.43%) | 3.88M | - | - |
Selling General And Administrative | 53M (+11.87%) | 48M (+2.24%) | 46M (+4.66%) | 44M (+0.84%) | 44M (+9.67%) | 40M (-10.74%) | 45M (+12.45%) | 40M (+4.19%) | 38M (+2.16%) | 38M (+0.75%) | 37M (-0.93%) | 38M (+12.02%) | 34M (-2.21%) | 34M (-0.38%) | 34M (+4.58%) | 33M (-8.16%) | 36M (-33.72%) | 54M (+104.14%) | 27M (+2.35%) | 26M (+35.90%) | 19M (-66.67%) | 57M (+247.39%) | 16M | - | - |
Operating Expenses | 62M (+11.83%) | 55M (+2.67%) | 54M (+2.84%) | 52M (+1.31%) | 52M (+11.98%) | 46M (-9.10%) | 51M (+11.17%) | 46M (-0.97%) | 46M (+5.12%) | 44M (+3.85%) | 42M (-3.20%) | 44M (+13.74%) | 38M (-2.21%) | 39M (-3.01%) | 41M (+10.44%) | 37M (-12.95%) | 42M (-34.39%) | 64M (+99.57%) | 32M (+2.84%) | 31M (+35.48%) | 23M (-68.89%) | 74M (+264.88%) | 20M | - | - |
Depreciation And Amortization | 340K (-66.00%) | 1.00M | - | - | 320K (-64.44%) | 900K | - | - | 330K (-70.54%) | 1.12M | - | - | 360K (-66.67%) | 1.08M | - | - | 320K (-67.68%) | 990K | - | - | 340K (-76.87%) | 1.47M | - | - | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | 7.92M (-52.77%) | 17M (+149.18%) | 6.73M (+50.22%) | 4.48M | -3.09M | 1.68M | -12.89M (+57.39%) | -8.19M (-42.49%) | -14.24M (+44.72%) | -9.84M (+100.41%) | -4.91M (-69.27%) | -15.98M (+20.33%) | -13.28M (-12.46%) | -15.17M (-19.22%) | -18.78M (-0.74%) | -18.92M (-34.92%) | -29.07M (-39.78%) | -48.27M (+98.15%) | -24.36M (-5.54%) | -25.79M (+54.06%) | -16.74M (-76.02%) | -69.80M (+408.01%) | -13.74M | - | - |
Ebit | 7.92M (-52.77%) | 17M (+149.18%) | 6.73M (+50.22%) | 4.48M | -3.09M | 1.68M | -12.89M (+57.39%) | -8.19M (-42.49%) | -14.24M (+44.72%) | -9.84M (+100.41%) | -4.91M (-69.27%) | -15.98M (+20.33%) | -13.28M (-12.46%) | -15.17M (-19.22%) | -18.78M (-0.74%) | -18.92M (-34.92%) | -29.07M (-39.78%) | -48.27M (+98.15%) | -24.36M (-5.54%) | -25.79M (+54.06%) | -16.74M (+1.33%) | -16.52M (+20.23%) | -13.74M (-42.99%) | -24.10M (-17.41%) | -29.18M |
EBITDA | 8.25M (-47.35%) | 16M (+98.61%) | 7.89M (+45.30%) | 5.43M | -2.77M (+197.85%) | -930.00K (-91.76%) | -11.28M (+79.33%) | -6.29M (-54.81%) | -13.92M (+40.04%) | -9.94M (+75.00%) | -5.68M (-59.40%) | -13.99M (+8.37%) | -12.91M (+22.60%) | -10.53M (-42.08%) | -18.18M (-21.23%) | -23.08M (-19.72%) | -28.75M (-39.46%) | -47.49M (+96.16%) | -24.21M (-5.87%) | -25.72M (+56.83%) | -16.40M (+8.47%) | -15.12M (+10.61%) | -13.67M (-43.28%) | -24.10M (-17.41%) | -29.18M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Expense | 6.88M (-3.78%) | 7.15M (-1.65%) | 7.27M (-1.22%) | 7.36M (+0.68%) | 7.31M (-5.06%) | 7.70M (-1.16%) | 7.79M (-2.14%) | 7.96M (+13.23%) | 7.03M (+0.14%) | 7.02M (+2.48%) | 6.85M (+4.90%) | 6.53M (+4.98%) | 6.22M (+98.09%) | 3.14M (-21.30%) | 3.99M (+15.65%) | 3.45M (-1.99%) | 3.52M (+95.56%) | 1.80M (0.00%) | 1.80M (0.00%) | 1.80M (+0.56%) | 1.79M (-78.51%) | 8.33M (+257.51%) | 2.33M | - | - |
Net Interest Income | - | - | - | - | - | 7.03M | - | - | -7.03M (+0.14%) | -7.02M (+2.48%) | -6.85M (+4.90%) | -6.53M (+4.98%) | -6.22M (+98.09%) | -3.14M (-21.30%) | -3.99M (+15.65%) | -3.45M (-1.99%) | -3.52M (+95.56%) | -1.80M (0.00%) | -1.80M (+0.56%) | -1.79M (0.00%) | -1.79M (-78.51%) | -8.33M (+257.51%) | -2.33M | - | - |
Other Non Operating Income | -5.68M (-76.66%) | -24.34M (+298.36%) | -6.11M (-4.68%) | -6.41M (+4.57%) | -6.13M (-73.87%) | -23.46M (+280.23%) | -6.17M (+1.65%) | -6.07M (+37.02%) | -4.43M (-77.27%) | -19.49M (+156.11%) | -7.61M (+67.62%) | -4.54M (+27.53%) | -3.56M (-74.82%) | -14.14M (+317.11%) | -3.39M (-55.45%) | -7.61M (+50.69%) | -5.05M (-33.29%) | -7.57M (+358.79%) | -1.65M (-4.62%) | -1.73M (+3.59%) | -1.67M (-78.31%) | -7.70M (+240.71%) | -2.26M | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | 550K | - | - | - | -57.10M | - | - | - | -63.50M | - | - | - | -96.08M | - | - | - | -122.72M | - | - | - | - | - | - | - |
Income Tax Expense | - | - | - | - | - | - | -3.32M | 750K (+141.94%) | 310K | -240.00K (-29.41%) | -340.00K (-49.25%) | -670.00K | - | -340.00K (0.00%) | -340.00K (0.00%) | -340.00K (-17.07%) | -410.00K | - | - | - | - | -110.00K | - | - | - |
Net Income From Continuing Operations | 2.23M (-79.87%) | 11M (+1687.10%) | 620K | -1.93M (-79.07%) | -9.22M (+80.43%) | -5.11M (-67.53%) | -15.74M (+4.93%) | -15.00M (-20.97%) | -18.98M (+41.75%) | -13.39M (+9.84%) | -12.19M (-38.56%) | -19.84M (+17.88%) | -16.83M (+30.16%) | -12.93M (-40.77%) | -21.83M (-16.62%) | -26.18M (-22.34%) | -33.71M (-33.63%) | -50.79M (+95.27%) | -26.01M (-5.45%) | -27.51M (+49.43%) | -18.41M (-15.78%) | -21.86M (+36.63%) | -16.00M (-33.61%) | -24.10M (-17.41%) | -29.18M |
Net Income | 2.23M (-79.87%) | 11M (+1687.10%) | 620K | -1.93M (-79.07%) | -9.22M (+80.43%) | -5.11M (-67.53%) | -15.74M (+4.93%) | -15.00M (-20.97%) | -18.98M (+41.75%) | -13.39M (+9.84%) | -12.19M (-38.56%) | -19.84M (+17.88%) | -16.83M (+30.16%) | -12.93M (-40.77%) | -21.83M (-16.62%) | -26.18M (-22.34%) | -33.71M (-33.63%) | -50.79M (+95.27%) | -26.01M (-5.45%) | -27.51M (+49.43%) | -18.41M (-15.78%) | -21.86M (+36.63%) | -16.00M (-33.61%) | -24.10M (-17.41%) | -29.18M |
Comprehensive Income Net Of Tax | 2.24M (+307.27%) | 550K (-11.29%) | 620K | -1.93M (-79.07%) | -9.22M (-83.19%) | -54.84M (+248.85%) | -15.72M (+4.80%) | -15.00M (-21.01%) | -18.99M (-69.50%) | -62.26M (+412.01%) | -12.16M (-38.86%) | -19.89M (+18.11%) | -16.84M (-82.21%) | -94.65M (+333.78%) | -21.82M (-16.62%) | -26.17M (-22.46%) | -33.75M (-72.51%) | -122.76M (+371.97%) | -26.01M (-5.49%) | -27.52M (+49.32%) | -18.43M (-79.79%) | -91.18M (+465.98%) | -16.11M | - | - |